Want obesity drugs covered by insurance? Telehealth companies have a big say - NPR

Telehealth companies offer lifestyle support so people taking obesity drugs can have the most success losing weight. But employers also want the telehealth providers to limit spending on the drugs.

Sarah Johnson Sarah Johnson · · 1 min read · 4 views

Share this article

Want obesity drugs covered by insurance? Telehealth companies have a big say - NPR

Want obesity drugs covered by insurance? Telehealth companies have a big say - NPR

Sarah Johnson · Jun 14, 2026

Telehealth companies offer lifestyle support so people taking obesity drugs can have the most success losing weight. But employers also want the telehealth providers to limit spending on the drugs.

Primary care doctors raise alarm as telehealth companies get involved in obesity drugs

June 14, 20265:00 AM ET Heard on Weekend" target="_blank" rel="noopener noreferrer nofollow">https://www.npr.org/programs/weekend-edition-sunday/nx-s1-5828958/weekend-edition-sunday-for-june-14-2026">Weekend Edition Sunday

GLP-1 apps raise hurdles

" target="_blank" rel="noopener noreferrer nofollow">https://ondemand.npr.org/anon.npr-mp3/npr/wesun/2026/06/20260614_wesun_want_obesity_drugs_covered_by_insurance_telehealth_companies_have_a_big_say.mp3?t=progseg&e=nx-s1-5828958&p=10&seg=4&d=305&size=4888495&sc=siteplayer&aw_0_1st.playerid=siteplayer"> Listen · 5:05 5:05 https://www.npr.org/transcripts/nx-s1-5805984" data-metrics-ga4='{"category":"audio","action":"audio_click_transcript","storyId":"nx-s1-5805984","mediaId":"nx-s1-9809702","title":"Primary care doctors raise alarm as telehealth companies get involved in obesity drugs","type":"ondemand"}' > Transcript Toggle more options

https://www.npr.org/2026/06/14/nx-s1-5805984/glp1-telehealth-weight-loss-drugs" target="_blank" rel="noopener noreferrer" class="inline-block bg-blue-600 hover:bg-blue-700 text-white font-semibold px-6 py-3 rounded-lg transition">Read Full Article on NPR

How did this make you feel?

Comments (0)

Log in or create an account to leave a comment.

No comments yet. Be the first!